Research Center for Functional Materials (RCFM), National Institute for Materials Science (NIMS), 1-1Namiki, Tsukuba, Ibaraki 305-0044, Japan.
Department of Bioengineering, University of Washington, USA.
Biomater Sci. 2021 Jul 13;9(14):4870-4879. doi: 10.1039/d1bm00349f.
Early diagnosis of infectious diseases is one of the current prevalent challenges, especially in low and limited resource settings where simple, fast, portable, cheap, and sensitive diagnostic approaches are needed. Lateral flow immunoassay (LFIA) is a common, rapid screening assay. However, the low assay sensitivity limits the utility of LFIA for specimens with low pathogenic loads (early infection stages). Antibodies conjugated with stimulus-responsive polymers have been previously utilized to improve assay sensitivity for detection of biomarkers at low concentrations. However, the loss of antibody affinity after polymer conjugation remains a significant challenge. In this study, we developed poly(N-isopropylacrylamide-co-N-(2-hydroxyisopropyl)acrylamide-co-strained alkyne-isopropylacrylamide), a novel polymer for biomarker enrichment, by polymer conjugation after antibody-antigen recognition. We employed and promoted the click chemistry in situ, to facilitate highly specific conjugation between novel temperature-responsive polymers and antibody-antigen complexes. This method could suppress the decrease in the binding constant associated with polymer conjugation (>20-fold). The conjugation was successfully demonstrated in body fluids such as urine and saliva. We achieved >5-fold antigen enrichment via thermal precipitation by conjugating polymers to the antibodies after antigen recognition. Concentrated biomarkers resulted in improved LFIA detection. This approach can potentially be utilized to improve diagnostic tests for infectious diseases in low and limited resource settings.
传染病的早期诊断是当前面临的挑战之一,特别是在资源有限的低收入环境中,需要简单、快速、便携、廉价和敏感的诊断方法。侧向流动免疫分析(LFIA)是一种常见的快速筛选检测方法。然而,低检测灵敏度限制了 LFIA 在低病原体负荷(早期感染阶段)标本中的应用。具有刺激响应聚合物的抗体已被用于提高低浓度生物标志物检测的检测灵敏度。然而,聚合物偶联后抗体亲和力的丧失仍然是一个重大挑战。在这项研究中,我们通过抗体-抗原识别后聚合物偶联,开发了一种新型的用于生物标志物富集的聚合物聚(N-异丙基丙烯酰胺-co-N-(2-羟丙基)丙烯酰胺-co-应变炔丙基异丙基丙烯酰胺)。我们采用并促进了点击化学原位反应,以促进新型温度响应聚合物和抗体-抗原复合物之间的高度特异性偶联。该方法可以抑制与聚合物偶联相关的结合常数下降(> 20 倍)。该方法在尿液和唾液等体液中得到了成功的验证。我们通过在抗原识别后将聚合物与抗体偶联,实现了> 5 倍的抗原浓缩,通过热沉淀富集。浓缩的生物标志物提高了 LFIA 的检测效果。这种方法可用于改善资源有限的低收入环境中的传染病诊断测试。